The role of oral controlled release matrix tablets in drug delivery systems

BioImpacts

Volumn 2, Issue 4, 2012, Pages 175-187

  Nokhodchi, Ali ^a   Raja, Shaista ^a   Patel, Pryia ^a   Asare Addo, Kofi ^b  

^a MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

^b UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

Author keywords

Diffusion; Erosion; Kinetics of drug release; Matrix tablet; Sustained release

Indexed keywords

ALGINIC ACID; CARBOXYMETHYLCELLULOSE; CATION; DICLOFENAC; HYDROXYPROPYLMETHYLCELLULOSE; THEOPHYLLINE;

ARTICLE; CHEMICAL STRUCTURE; CONTROLLED DRUG RELEASE; DISPERSIBLE TABLET; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG SOLUBILITY; ENCAPSULATION; HYDROPHILICITY; HYDROPHOBICITY; IONIC STRENGTH; MATRIX TABLET; OSMOTIC PRESSURE; PH; SUSTAINED RELEASE FORMULATION; SUSTAINED RELEASE PREPARATION; TABLET FORMULATION; TABLET PROPERTY; VISCOSITY;

EID: 84876799240     PISSN: 22285652     EISSN: 22285660     Source Type: Journal    
DOI: 10.5681/bi.2012.027     Document Type: Article

References (95)

1. Abrahamsson B, Albery T, Eriksson A, Gustafsson I and Sjoberg M. 2004. Food effects on tablet disintegration. Eur. J. Pharm. Sci, 22, 165-172.
2. Alderman DA. 1984. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. International Journal of Pharmaceutical Technology production, 5, 1-9.
3. th ed. Baltimore, USA: Lippincott Williams and Wilkins. pp: 260-267.
4. Al-Musaa S, Abu Farab D, and Badwan AA. 1999. Evaluation of parameters involved in preparation and release of drug loaded in crosslinked matrices of alginate. J. Control. Release, 57, 223-232.
5. Asare-Addo K, Levina M, Rajabi-Siahboomi AR and Nokodhchi A. 2011. Effect of ionic strength and pH of dissolution media on theophylline release from hypromellose matrix tablets-Apparatus USP III, simulated fasted and fed conditions. Carbohydrate Polymers, 86, 85-93.
6. rd ed. Philadelphia, USA: Churchill Livingstone Elsevier. pp: 99-102.
7. Bajwa GS, Hoebler K, Sammon C, Timmins P and Melia CD. 2006. Microstructural imaging of early gel layer formation in HPMC matrices. J Pharm Sci, 95, 2145-2157.
8. Bettini R, Catellani PL, Santi P, Massiomo G, Peppas NA and Colombo P. 2001. Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate. J. Control. Release, 70, 381-391.
9. Bettini R, Colombo P and Peppas NA. 1995. Solubility effects on drug transport through pH sensitive, swelling controlled release systems: Transport of theophylline and metoclopramide monohydrochloride. J. Control. Release, 37, 105-111.
10. Bonferoni MC, Rossi S, Ferrari F, Bertoni M and Caramella C. 1995. Influence of medium on dissolution-erosion behaviour of sodium carboxymethylcellulose and on viscoelastic properties of gels. Int. J. Pharm, 117, 41-48.
11. Bonferoni MC, Rossi S, Ferrari F, Bertoni M, and Caramella C. 1995. Influence of medium on dissolution-erosion behaviour of Na carboxymethylcellulose and viscoelastic peopertis of gels. Int. J. Pharm, 117, 41-48.
12. Braccini I, Grasso RP and Serge Pérez S. 1999. Conformational and configurational features of acidic polysaccharides and their interactions with calcium ions: a molecular modeling investigation. Carbohydrate Research, 317, 119-130.
13. Caramella C, Ferrari F, Bonferoni MC, Ronchi M and Colombo P. 1989. Rheological properties and diffusion dissolution behaviour of hydrophilic polymer. Chem. Pharm. Bull, 128, 298-301.
14. Chan LW, Ching AL, Heng PWS, and Liew CV. 2007. Mechanistic study on hydration and drug release behaviour of sodium alginate compacts. Drug Dev. Ind. Pharm, 33, 667-676.
15. Charman WN, Porter CJH, Mithani S and Dressman JB. 1997. Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. Journal of Pharmaceutical Sciences, 86, 269-282.
16. Chen X, Wen H and Park K. 2010. Challenges and new technologies of oral controlled release. Oral controlled release formulation design and drug delivery: Theory to Practice, 16, 257-277.
17. Ching AL, Liew CV, Heng PWS, and Chan LW. 2008. Impact of cross-linker on alginate matrix integrity and drug release. Int. J. Pharm, 355, 259-268.
18. Colombo P, Bettini R, Santi P and Peppas NA. 2000. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm. Sci .Technol.Today, 3, 198-204.
19. Colombo P. 1993. Swelling-controlled release in hydrogel matrices for oral route. Adv, Drug. Deliv. Rewiews, 11, 37-57.
20. Colombo P. 1993. Swelling: Controlled release in hydrogel matrices for oral route. Advanced drug delivery, 11, 37-57.
21. Colorcon limited. 2005. [Accessed Oct. 10, 2011]. Available at: http://www.colorcon.com/formulation/excipient-functionality/rate-control ling-polymers
22. Conti S, Maggi L, Segale L, Ochoa EM, Conte U, Grenier P et al. 2007. Matrices containing NaCMC and HPMC 1. Dissolution performance characterization. Int. J. Pharm, 333, 136-142.
23. Dash A and Cudworth G. 1998. Therpeutic applications of implantable drug delivery systems. J. Pharmacol. Toxicol. Meth, 40, 1-12.
24. Desai SJ, Simonelli AP and Higuchi WI. 1965. Investigation of factors influencing release of solid drug dispersed in inert matrices. J. Pharm. Sci, 54, 1459-1464.
25. Desai SJ, Singh P, Simonelli AP and Higuchi WI. 1966. Investigation of factors influencing release of solid drug dispersed in inert matrices II. J. Pharm. Sci, 55, 1224-1229.
26. Diakidoua A, Vertzonia M, Abrahamssonb B, Dressmanc J and Reppasa C. 2009. Simulation of gastric lipolysis and prediction of felodipine release from a matrix tablet in the fed stomach. Eur. J. Pharm Sci, 37, 133-140.
27. DiMatteo MR and DiNicola DD. 1982. Achieving patient compliance: the psychology of the medical practioners role. New York: Pergamon press.
28. Ferrero-Rodriquez C, Bruneau N, Barra J, Alfonso D and Doelker E. 2000. Handbook of Pharmaceutical Controlled Release Technology. New York, USA:Marcel Dekker. pp. 465-503.
29. Giunchedi P, Gavini E, Moretti MDL and Pirisino G. 2000. Evaluation of alginate compressed matrices as prolonged drug delivery systems. AAPS. Pharm. Sci. Tech, 1(3), Article 19.
30. Grant GT, Morris ER, Rees DA, Smith PJC and Thom D. 1973. Biological interactions between polysaccharides and divalent cations: The egg-box model. FEBS Lett, 32(1), 195-198.
31. Grundy JS and Foster RT. 1996. The nifedipine gastrointestinal system: Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties. Clinical Pharmacokinetics, 30, 28-51.
32. Gupta PK and Robinson JR. 1992. Oral controlled release delivery. In: Kyodenius A. (Ed). Treatise on Controlled Drug Delivery. New York:Marcel Dekker.
33. Higuchi T. 1963. Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci, 52, 1145-1149.
34. Indian Academy of Sciences. 2010. [Accessed Nov. 25, 2011]. Available at: http://www.ias.ac.in/initiat/sci_ed/resources/chemistry/Viscosity.pdf
35. Jayanthi B, Manna PK, Madhusudhan S, Mohanta GP and Manavalan R. 2011. Per oral extended release products- An overview. Journal of Applied Pharmaceutical Science, 1, 50-55.
36. Johnson JL, Holinej J and Williams MD. 1993. Influence of ionic strength on matrix integrity and drug release from hydroxypropyl cellulose compacts. Int. J. Pharm, 2, 151-159.
37. Kamel S, Ali N, Jahangir K, Shah SM and El-Gendy AA. 2008. Pharmaceutical significance of cellulose: A review. eXPRESS Polymer Letters, 2, 758-778.
38. Kayser O, Lemke A and Hernandez-Trejo N. 2005. The Impact of Nanobiotechnology on the Development of New Drug. Current Pharmaceutical Biotechnology, 6, 3-5.
39. Khan MZI. 1996. Dissolution testing for sustained or controlled release oral dosage forms and correlation with in vivo data: challenges and opportunities. Int. J. Pharm, 140, 131-143.
40. Kim C. 2000. Controlled release dosage form design. Florida, USA: CRC Press.
41. Kojima H, Yoshihara K, Sawada T, Kondo H and Sako K. 2008. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets. Eur. J. Pharm. Biopharm, 70, 556-562.
42. Korsmeyer RW, Gurny R, Doelker E, Buri P and Peppas NA. 1983. Mechanisms of solute release from porous hydrophillic polymers. Int. J. Pharm, 15, 25-35.
43. Lapidus H and Lordi NG. 1966. Some factors affecting the release of a water-soluble drug from compressed hydrophilic matrices. J. Pharm. Sci, 55, 840-843.
44. Lapidus H and Lordi NG. 1968. Drug release from compressed hydrophilic matrices. J. Pharm. Sci, 57, 1292-1301.
45. Lee HY, Chan LWand Heng PWS. 2005. Influence of partially cross-linked alginate used in the production of alginate microspheres by emulsification. J. Microencapsul, 22, 275-280.
46. Lee PI and Peppas NA. 1987. Prediction of polymer dissolution in swellable controlled-release systems. J. Control. Release, 6, 207-215.
47. Lee PI. 1985. Kinetics of drug release from hydrogel matrices. J. Control. Release, 2, 277-288.
48. Levina M and Rajabi-Siahboomi AR. 2004. The influence of excipients on drug release from Hydroxypropylmethylcellulose matrices. J. Pharm. Sci, 97, 2746-2754.
49. Liew CV, Chan LW, Ching AL and Heng PWS. 2006. Evaluation of sodium alginate as drug release modifier in matrix tablets. Int. J. Pharm, 309, 25-37.
50. Lindahl A, Ungell AL, Knutson L and Lennernas H. 1997. Characterisation of fluids from the stomach and proximal jejunum in men and women. Journal of Pharmaceutical Research, 14, 497-502.
51. Lindner WD and Lippold BC. 1995. Embeddings with High or Low Susceptibility to Hydrodynamic Stress. Journal of Pharmaceutical Research, 12, 1781-1785.
52. rd ed. Philadelphia, USA: Lea and Febiger. pp. 430-456.
53. Maderuelo C, Zarzuelo A and Lanao JM. 2011. Critical factors in the release of drugs from sustained release hydrophillic matrices. J. Control. Release, 154, 2-19.
54. Maggi L, Segale L, Torre ML, Machiste EO and Conte U. 2002. Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for controlled release of a water-soluble drug. Dimensionality study. Biomaterials, 23, 1113-1119.
55. 3+ on the release rate of propranolol hydrochloride from sodium carboxymethylcellulose matrices. Daru, 17, 131-138.
56. Nair AB, Vyas H and Kumar A. 2010. Controlled release matrix uncoated tablets of enalapril maleate using HPMC alone. Journal of Basic and Clinical Pharmacy, 001(002), 71-5.
57. Narasimhan B and Peppas NA. 1997. Molecular analysis of drug delivery systems controlled by dissolution of the polymer carrier. J Pharm Sci, 86(3), 297-304.
58. Nerurkar J, Jun HW, Price JC and Park MO. 2005. Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates. Eur. J. Pharm Biopharm, 61, 56-68.
59. Nokhodchi A and Tailor A. 2004. In situ cross-linking of sodium alginate with calcium and aluminium ions to sustain the release of theophylline from polymeric matrices. IL Farmaco, 59, 999-1004.
60. Nokhodchi A, Rubenstein MH and Ford JH. 1995. The effect of particle size and viscosity grade on the compaction properties of hydroxypropylmethylcellulose 2208. Int. J. Pharma, 126, 189-197.
61. Peppas NA, Buresa P, Leobandunga W and Ichikawab H. 2000. Hydrogels in pharmaceutical formulations. Eur. J. Pharma. Biopharm, 50, 27-46.
62. Peppas NA, Gurny R, Doelker E and Buri P. 1980. Modelling of drug diffusion through swellable polymeric systems. Journal of Membrane Science, 7, 241-253.
63. Peppas NA. 1984. Mathematical modelling of diffusion processes in drug delivery polymeric systems. In: Smolen VF and Ball L (Eds.). Controlled Drug Bioavailability, Vol. 1. New York: John Wiley & Sons. pp. 203-237.
64. Prajapati GB and Patel RK. 2010. Design and in vitro evaluation of novel nicorandil sustained release matrix tablets based on combination of hydrophillic and hydrophobic matrix systems. International Journal of Pharmaceutical Sciences review and research, 1: 33-35.
65. Rahman M, Roy S, Das SC, Jha MK, Begum T, Ahsan Q et al. 2011. Evaluation of various grades of hydroxypropyl methylcellulose matrix systems as oral sustained release drug delivery systems. Journal of Pharmaceutical Sciences and Research, 3, 930-938.
66. Rajabi-Siahboomi AR, Bowtell RW, Mansfield P, Davies MC and Melia CD. 1996. Structure and behavior in hydrophilic matrix sustained release dosage forms: 4. Studies of water mobility and diffusion coefficients in the gel layer of HPMC tablets using NMR imaging. Pharm Res, 13, 376-380.
67. Rajput GC, Majmudar FD, Patel JK, Thakor RS, Patel BP and Rajgor NB. 2010. Stomach specific mucoadhesive microsphere as a controlled drug delivery system. International Journal on Pharmaceutical and Biological Research, 1, 30-41.
68. Rimmer S. 2005. Biomedical hydrogels; Biochemistry, manufacture and medical applications. Cambridge, UK: Woodhead Publishing.
69. Ritger PL and Peppas NA. 1987. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J. Control. Release, 5, 37-42.
70. Saeedi M, Akbari J, Enayatifard R, Semnani KM, Tahernia M, Valizadeh H. 2009. In situ cross-linking of polyanionic polymers to sustain the drug release from theophylline tablets. Iranian J. Pharm. Res, 8, 241-249.
71. Sansom NL. 1999. Oral extended release products. Australian prescriber, 22, 88-90.
72. Siahi MR, Jalali MB, Monajjemzadeh F, Ghaffari F and Azarmi S. 2005. Design and Evaluation of 1- and 3-Layer Matrices of Verapamil Hydrochloride for Sustaining Its Release. AAPS Pharm. Sci. Tech, 6(4), Article 77.
73. Siahi-Shadbad MR, Asare-Addo K, Azizian K, Hassanzadeh D and Nokhodchi A. 2011. Release behaviour of propranolol HCl from hydrophilic matrix tablets containing psyllium powder in combination with hydrophilic polymers. AAPS Pharm. Sci. Tech, 12(4), 1176-1181.
74. Siepmann J and Peppas NA. 2000. Hydrophilic matrices for controlled drug delivery: an improved mathematical model to predict the resulting drug release kinetics (the "sequential layer" model). Pharm Res, 17, 1290-1298.
75. Siepmann J and Peppas NA. 2001a. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48, 139-157.
76. Siepmann J and Peppas NA. 2001b. Mathematical modeling of controlled drug delivery. Adv Drug Deliv Rev, 48, 137-138.
77. Siepmann J, Podual K, Sriwongjanya M, Peppas NA and Bodmeier R. 1999. A new model describing the swelling and drug release kinetics from hydroxypropyl methylcellulose tablets. J Pharm Sci, 88, 65-72.
78. Siepmann J, Siepmann F. 2008. Mathematical modelling of drug delivery. Int. JU. Pharm, 364, 328-343.
79. Siepmann J, Streubel A and Peppas NA. 2002. Understanding and predicting drug delivery from hydrophilic matrix tablets using the "sequential layer" model. Pharm Res, 19, 306-314.
80. Singh P, Desai JS, Simonelli PA and Higuchi LW. 1968. Role of wetting on the rate of drug release from inert matrices. J. Pharm. Sci, 57, 217-226.
81. Skoug JW, Mikelsons MV, Vigneron CN and Stemm NL. 1993. Qualitative evaluation of the mechanism of release of matrix sustained release dosage forms by measurement of polymer release. J. Control. Release, 27, 227-245.
82. Sood A and Panchagnula R. 2010. Drug release evaluation of diltiazem CR preparations. Int. J. Pharm, 175, 95-107.
83. Streubel A, Siepmann J, Dashevsky A and Bodmeier R. 2000. pH-independent release of a weakly basic drug from water insoluble and soluble matrix tablets. J. Control. Release, 67, 101-110.
84. Sudha BS, Sridhar BK and Srinatha A. 2010. Modulation of Tramadol Release from a Hydrophobic Matrix: Implications of Formulations and Processing Variables. AAPS Pharm. Sci. Tech, 11, 433-440.
85. Sujja-Areevath J, Munday DL, Cox PJ and Khan KA. 1998. Relationship between swelling, erosion and drug release in hydrophilic natural gum mini matrix formulations. Eur. J. Pharm. Sci, 6, 207-217.
86. Tahara K, Yamamoto K and Nishihata T. 1995. Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxypropyl methylcellulose 2910. J. Control. Release, 35, 59-66.
87. Thawatchai P. 2008. Variables Influencing Drug Release from Layered Matrix System Comprising Hydroxypropyl Methylcellulose. AAPS Pharm. Sci. Tech, 9(2), 668-674.
88. The Dow Chemical Company. 2000. [Accessed Oct. 2. 2011]. Available at: http://www.colorcon.com/literature/marketing/mr/Extended%20Release/METHO CEL/English/hydroph_matrix_broch.pdf
89. Tiwari SB and Rajabi-Siahboomi AR. 2008. Modulation of drug release from hydrophilic matrices. Pharmaceutical Technology, Europe, 1, 1-8.
90. Tiwari SB, Murthy K, Pai MR, Mehta PR and Chowdary PB. 2003. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. Pharm. Sci. Tech, 4, 1-6.
91. Tiwari SB, Murthy TK, Pai MR, Mehta PR and Chowdray PB. 2003. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix systems. AAPS Pharmaceutical Sciences Technology, 4, E31.
92. Tongwen X and Binglin H. 1998. Mechanism of sustained drug release in diffusion controlled polymer matrix application of percolation theory. Int. J. Pharma, 170, 139-149.
93. Tritt-Goc J and Kowalczuk J. 2005. Spatially resolved solvent interaction with glassy HPMC polymer studied by magnetic resonance microscopy. Solid State Nuclear Magentic Resonance, 28, 250-257.
94. Varshosaz J, Tavakoli N and Kheirolahi F. 2006. Use of Hydrophilic Natural Gums in Formulation of Sustained-release Matrix Tablets of Tramadol Hydrochloride. APPS Pharm. Sci. Tech, 7, Article 24.
95. Wan L, Heng P and Wong L. 1995.Matrix swelling: A simple model describing extent of swelling of HPMC matrices. Int. J. Pharm, 116, 159-168.